Skip to main content

Omission Bias

  • Chapter
  • First Online:
Cognitive Errors and Diagnostic Mistakes
  • 2582 Accesses

Abstract

Herbert was a 34-year-old man suffered from multiple sclerosis (MS) for 8 years. His initial symptom was trouble walking, and he was found to have multiple demyelinating lesions in his spine and brain. He was placed on glatiramer acetate, a safe, but only partially effective treatment. He continued to have multiple relapses with resultant progression in his disability. Five years into his disease course, he was using a cane and had developed cognitive and visual impairment. The decision was made to place him on natalizumab, a monoclonal antibody given intravenously every month. It is highly effective in preventing relapses in MS, however carries a significant risk for a potentially fatal viral infection known as progressive multiple focal leukoencephalopathy (PML). The causative virus is the JC virus, and Herbert had serum antibodies against the JC virus detected in his serum. In patients with significantly elevated antibody levels, the risk of PML is about one in 100. Based on Herbert’s blood tests, he had an approximately 1:1000 risk of contracting PML if continued on natalizumab.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peel M. Human rights and medical ethics. J R Soc Med. 2005;98(4):171–3. https://doi.org/10.1258/jrsm.98.4.171.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Trolley problem [Image file]. (n.d.). In: Wikipedia. Retrieved from https://en.wikipedia.org/wiki/Trolley_problem#/media/File:Trolley_problem.png.

  3. Greene JD, Sommerville RB, Nystrom LE, Darley JM, Cohen JD. An fMRI investigation of emotional engagement in moral judgment. Science. 2001;293(5537):2105–8. https://doi.org/10.1126/science.1062872.

    Article  CAS  PubMed  Google Scholar 

  4. Aberegg SK, Haponik EF, Terry PB. Omission bias and decision making in pulmonary and critical care medicine. Chest. 2005;128(3):1497–505. https://doi.org/10.1378/chest.128.3.1497.

    Article  PubMed  Google Scholar 

  5. DiBonaventura MD, Chapman GB. Do decision biases predict bad decisions? Omission bias, naturalness bias, and influenza vaccination. Med Decis Mak. 2008;28(4):532–9. https://doi.org/10.1177/0272989X07312723.

    Article  Google Scholar 

  6. Ritov I, Baron J. Reluctance to vaccinate: omission bias and ambiguity. J Behav Decis Mak. 1990;3:263–77. https://doi.org/10.1002/bdm.3960030404.

    Article  Google Scholar 

  7. Kertesz S, Satel S. (2017, Aug 17). Some people still need opioids. SLATE. Retrieved from http://www.slate.com/articles/health_and_science/medical_examiner/2017/08/cutting_down_on_opioids_has_made_life_miserable_for_chronic_pain_patients.html.

  8. National Safety Council. (n.d.). What are the odds of dying from. Retrieved 15 Sept 2018 from https://www.nsc.org/work-safety/tools-resources/injury-facts/chart.

  9. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–54. https://doi.org/10.1001/archinternmed.2010.355.

    Article  PubMed  Google Scholar 

  10. Johnson EJ, Goldstein DG. Defaults and donation decisions. Transplantation. 2004;78(12):1713–6. https://doi.org/10.1097/01.TP.0000149788.10382.B2.

    Article  PubMed  Google Scholar 

  11. Dholakia U. (2017, Nov 6). Why automating retirement savings may not be enough [Blog post]. Psychology Today. Retrieved from https://www.psychologytoday.com/us/blog/the-science-behind-behavior/201711/why-automating-retirement-savings-may-not-be-enough/.

  12. Patel MS, Day S, Small DS, Howell JT, Lautenbach GL, Nierman EH, Volpp KG. Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study. Ann Intern Med. 2014;161(10_Supplement):S44–52. https://doi.org/10.7326/M13-3001.

    Article  PubMed  Google Scholar 

  13. Gawande A. (2015, May 11). Overkill. The New Yorker. Retrieved from https://www.newyorker.com/magazine/2015/05/11/overkill-atul-gawande.

  14. Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274–86. https://doi.org/10.1001/jamainternmed.2014.6016.

    Article  PubMed  Google Scholar 

  15. Holly L. Commentary. Neurosurgery. 2013;72(Supplement 3):2–3. https://doi.org/10.1227/NEU.0b013e3182772981.

    Article  PubMed  Google Scholar 

  16. Morgan DJ, Dhruva SS, Wright SM, Korenstein D. Update on medical practices that should be questioned in 2015. JAMA Intern Med. 2015;175(12):1960–4. https://doi.org/10.1001/jamainternmed.2015.5614; Morgan DJ, Dhruva SS, Wright SM, Korenstein D. 2016 update on medical overuse: a systematic review. JAMA Intern Med. 2016;176(11):1687–92. https://doi.org/10.1001/jamainternmed.2016.5381.

  17. U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality. (2018, Aug). Radiation safety. Retrieved 15 Sept 2018 from https://psnet.ahrq.gov/primers/primer/27/radiation-safety.

  18. Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, Khorasani R. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251(1):175–84. https://doi.org/10.1148/radiol.2511081296.

    Article  PubMed  Google Scholar 

  19. U.S. Department of Health and Human Services. Food and Drug Administration. (2018, Aug 15) Initiative to reduce unnecessary radiation exposure from medical imaging. Retrieved 15 Sept 2018 from https://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/.

  20. Our Amazing World. (2016, Sept 22). Purdue Pharma OxyContin commercial [Video file]. Retrieved from https://www.youtube.com/watch?v=Er78Dj5hyeI.

  21. Weiss AJ, Bailey MK, O’Malley L, Barrett ML, Elixhauser A, Steiner CA. (2017). Patient characteristics of opioid-related inpatient stays and emergency department visits nationally and by state, 2014 [PDF file]. Statistical Brief #224. Retrieved from https://www.hcup-us.ahrq.gov/reports/statbriefs/sb224-Patient-Characteristics-Opioid-Hospital-Stays-ED-Visits-by-State.pdf.

  22. Katz J. (2017, June 5). Drug deaths in America are rising faster than ever. The New York Times. Retrieved from https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html.

  23. Centers for Disease Control and Prevention. (2017, Aug 30). Prescription opioid data. Retrieved 15 Sept 2018 from https://www.cdc.gov/drugoverdose/data/prescribing.html.

  24. Kaplan S. (2017, Nov 3). C.D.C. reports a record jump in drug overdose deaths last year. The New York Times. Retrieved from https://www.nytimes.com/2017/11/03/health/deaths-drug-overdose-cdc.html.

  25. National Institutes of Health, National Institute on Drug Abuse. (2018, Jan). Prescription opioids and heroin. Retrieved from https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-heroin-abuse/prescription-opioid-use-risk-factor-heroin-use.

  26. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use – United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;2017(66):265–9. https://doi.org/10.15585/mmwr.mm6610a1.

    Article  Google Scholar 

  27. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, ASB B, Kheterpal S, Nallamothu BK. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504. https://doi.org/10.1001/jamasurg.2017.0504.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Frieden J. (2016, June 13). Remove pain as 5th vital, sign, AMA urged. Medpage Today. Retrieved from https://www.medpagetoday.com/meetingcoverage/ama/58486.

  29. Guy GP, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;2017(66):697–704. https://doi.org/10.15585/mmwr.mm6626a4.

    Article  Google Scholar 

  30. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40(4):277.

    Google Scholar 

  31. Weiss AJ, Elixhauser A, Bae J, Encinosa W. (2006). Origin of adverse drug events in US hospitals, 2011: Statistical Brief# 158. Retrieved from https://www.hcup-us.ahrq.gov/reports/statbriefs/sb158.jsp.

  32. Centers for Disease Control and Prevention. (2018, Sept 10). Antibiotic/Antimicrobial resistance: biggest threats and data. Retrieved 15 Sept 2018 from https://www.cdc.gov/drugresistance/biggest_threats.html.

  33. Reardon S. WHO warns against ‘post-antibiotic’ era. Nature. 2014; https://doi.org/10.1038/nature.2014.15135.

  34. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50. https://doi.org/10.1016/S1473-3099(14)70780-7.

    Article  PubMed  Google Scholar 

  35. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. https://doi.org/10.1517/14740338.2013.827660.

    Article  PubMed  Google Scholar 

  36. Evans I, Thornton H, Chalmers I, Glasziou P. Testing treatments: better research for better healthcare. 2nd ed. London: Pinter & Martin Ltd; 2011.

    Google Scholar 

  37. Baum M, Houghton J. Contribution of randomised controlled trials to understanding and management of early breast cancer. BMJ. 1999;319:568. https://doi.org/10.1136/bmj.319.7209.568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Farquhar CM, Basser R, Marjoribanks J, Lethaby AE. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database of Systematic Reviews. 2016;2016(5):CD003139. https://doi.org/10.1002/14651858.CD003139.pub.3.

  39. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16. https://doi.org/10.1056/NEJMoa070829.

    Article  CAS  PubMed  Google Scholar 

  40. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(4):312–9. https://doi.org/10.1001/archinternmed.2011.1484.

    Article  PubMed  Google Scholar 

  41. Desai NR, Bradley SM, Parzynski CS, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Ader J, Soufer A, Krumholz HM, Curtis JP. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314(19):2045–53. https://doi.org/10.1001/jama.2015.13764.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Al-Lamee R, Thompson D, Dehbi H-M, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40. https://doi.org/10.1016/S0140-6736(17)32714-9.

    Article  PubMed  Google Scholar 

  43. Gorski D. (2017, Nov 6). ORBITA: another clinical trial demonstrating the need for sham controls in surgical trials. Science-Based Medicine. Retrieved from https://sciencebasedmedicine.org/orbita-another-clinical-trial-demonstrating-the-need-for-sham-controls-in-surgical-trials/.

  44. Flapan D. (2014, Apr 17). FDA warns against morcellation in hysterectomy, myomectomy. Medscape. Retrieved from https://www.medscape.com/viewarticle/823776.

  45. Siemieniuk RA, Harris IA, Agoritsas T, Poolman RW, Brignardello-Petersen R, Van de Velde S, Buchbinder R, Englund M, Lytvyn L, Quinlan C, Helsingen L, Knutsen G, Olsen NR, Macdonald H, Hailey L, Wilson HM, Lydiatt A, Kristiansen A. Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline. BMJ. 2017;357:j1982. https://doi.org/10.1136/bmj.j1982.

    Article  PubMed  PubMed Central  Google Scholar 

  46. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85. https://doi.org/10.1056/NEJMoa1001286.

    Article  CAS  Google Scholar 

  47. Giugliano D, Esposito K. Clinical inertia as a clinical safeguard. JAMA. 2011;305(15):1591–2. https://doi.org/10.1001/jama.2011.490.

    Article  CAS  PubMed  Google Scholar 

  48. Periyakoil VS, Neri E, Fong A, Kraemer H. Do unto others: doctors’ personal end-of-life resuscitation preferences and their attitudes toward advance directives. PLoS One. 2014;9(5):e98246. https://doi.org/10.1371/journal.pone.0098246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Walsh D. (2014, May 29), Why your doctor probably has a “Do Not Resuscitate” order. Time. Retrieved from http://time.com/131443/why-your-doctor-probably-has-a-do-not-resuscitate-order/.

  50. Murray K. (2011, Nov 30). How doctors die. Zocalo. Retrieved from http://www.zocalopublicsquare.org/2011/11/30/how-doctors-die/ideas/nexus/.

  51. Gallo JJ, Straton JB, Klag MJ, Meoni LA, Sulmasy DP, Wang NY, Ford DE. Life-sustaining treatments: what do physicians want and do they express their wishes to others? J Am Geriatr Soc. 2003;51(7):961–9. https://doi.org/10.1046/j.1365-2389.2003.51309.x.

    Article  PubMed  Google Scholar 

  52. U. S. Department of Health and Human Services, Centers for Medicare & Medicaid Services. (2018, Jan 8). National health expenditure data: historical. Retrieved from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsHistorical.html.

  53. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513–6. https://doi.org/10.1001/jama.2012.362.

    Article  CAS  PubMed  Google Scholar 

  54. Jena AB, Prasad V, Goldman DP, Romley J. Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings. JAMA Intern Med. 2015;175(2):237–44. https://doi.org/10.1001/jamainternmed.2014.6781.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Cunningham SA, Mitchell K, Narayan KV, Yusuf S. Doctors’ strikes and mortality: a review. Soc Sci Med. 2008;67(11):1784–8. https://doi.org/10.1016/j.socscimed.2008.09.044.

    Article  PubMed  Google Scholar 

  56. Hendee WR, Becker GJ, Borgstede JP, Bosma J, Casarella WJ, Erickson BA, Maynard CD, Thrall JH, Wallner PE. Addressing overutilization in medical imaging. Radiology. 2010;257(1):240–5. https://doi.org/10.1148/radiol.10100063.

    Article  PubMed  Google Scholar 

  57. Terhune C. (2017, May 25). Americans waste $200 billion every year on medical tests they don’t need, experts say. Los Angeles Times. Retrieved from http://www.latimes.com/business/la-fi-medical-tests-20170526-story.html.

  58. Terhune C. (2017, May 20). Needless medical test not only cost $200 billion, they can do harm. CNN: Money. https://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html.

  59. Woolford SJ, Clark SJ, Gebremariam A, Davis MM, Freed GL. To cut or not to cut: physicians’ perspectives on referring adolescents for bariatric surgery. Obes Surg. 2010;20(7):937–42. https://doi.org/10.1007/s11695-010-0152-9.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Belluz J. (2017, Dec 18). Jewel’s story: how one teen battled obesity with medicine’s best — and most underused — tool. Vox. https://www.vox.com/science-and-health/2017/12/18/16707428/bariatric-surgery-teen-weight-loss-jewel.

  61. Ofri D. (2011, Oct 20). When doing nothing is the best medicine [Blog post]. The New York Times. Retrieved from https://well.blogs.nytimes.com/2011/10/20/when-doing-nothing-is-the-best-medicine/.

  62. Taleb NN. (n.d.). [Personal quote]. Retrieved 15 Sept 2018 from https://www.goodreads.com/quotes/699367-the-psychologist-gerd-gigerenzer-has-a-simple-heuristic-never-ask.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Howard, J. (2019). Omission Bias. In: Cognitive Errors and Diagnostic Mistakes. Springer, Cham. https://doi.org/10.1007/978-3-319-93224-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93224-8_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93223-1

  • Online ISBN: 978-3-319-93224-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics